Debra Wujcik

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

1. A randomized trial comparing the effect of two phone-based interventions on colorectal cancer screening adherence. Menon U, Belue R, Wahab S, Rugen K, Kinney AY, Maramaldi P, Wujcik D, Szalacha LA (2011) Ann Behav Med 42(3): 294-303
   › Primary publication · 21826576 (PubMed) · PMC3232176 (PubMed Central)
2. Well-done meat intake and meat-derived mutagen exposures in relation to breast cancer risk: the Nashville Breast Health Study. Fu Z, Deming SL, Fair AM, Shrubsole MJ, Wujcik DM, Shu XO, Kelley M, Zheng W (2011) Breast Cancer Res Treat 129(3): 919-28
   › Primary publication · 21537933 (PubMed) · PMC3775710 (PubMed Central)
3. Psychosocial determinants of mammography follow-up after receipt of abnormal mammography results in medically underserved women. Fair AM, Wujcik D, Lin JM, Zheng W, Egan KM, Grau AM, Champion VL, Wallston KA (2010) J Health Care Poor Underserved 21(1 Suppl): 71-94
   › Primary publication · 20173286 (PubMed) · PMC2927817 (PubMed Central)
4. Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource. Wujcik D, Wolff SN (2010) J Health Care Poor Underserved 21(1 Suppl): 38-50
   › Primary publication · 20173284 (PubMed) · PMC2964375 (PubMed Central)
5. Delay in diagnostic testing after abnormal mammography in low-income women. Wujcik D, Shyr Y, Li M, Clayton MF, Ellington L, Menon U, Mooney K (2009) Oncol Nurs Forum 36(6): 709-15
   › Primary publication · 19887359 (PubMed) · PMC3479661 (PubMed Central)
6. Obesity, gynecological factors, and abnormal mammography follow-up in minority and medically underserved women. Fair AM, Wujcik D, Lin JM, Grau A, Wilson V, Champion V, Zheng W, Egan KM (2009) J Womens Health (Larchmt) 18(7): 1033-9
   › Primary publication · 19558307 (PubMed) · PMC2851132 (PubMed Central)
7. Barriers to diagnostic resolution after abnormal mammography: a review of the literature. Wujcik D, Fair AM (2008) Cancer Nurs 31(5): E16-30
   › Primary publication · 18772653 (PubMed)
8. Timing is everything: methodologic issues locating and recruiting medically underserved women for abnormal mammography follow-up research. Fair AM, Wujcik D, Lin JM, Egan KM, Grau AM, Zheng W (2008) Contemp Clin Trials 29(4): 537-46
   › Primary publication · 18289943 (PubMed) · PMC2483696 (PubMed Central)
9. TITAN: modifying an innovative American program for use with a European audience. Ahlberg K, Dielenseger P, Dolan S, Foubert J, Munoz M, Ouwerkerk J, Uhlenhopp M, Wujcik D, Training Initiatives in Thrombocytopenia, Anemia, and Neutropenia Working Group, Appropriate Treatment Assures Quality (ATAQ) (2005) J Support Oncol 3(6 Suppl 4): 34-5
   › Primary publication · 16355561 (PubMed)
10. Pain-related distress and interference with daily life of ambulatory patients with cancer with pain. Wells N, Murphy B, Wujcik D, Johnson R (2003) Oncol Nurs Forum 30(6): 977-86
    › Primary publication · 14603355 (PubMed)
11. Improving cancer pain management through patient and family education. Wells N, Hepworth JT, Murphy BA, Wujcik D, Johnson R (2003) J Pain Symptom Manage 25(4): 344-56
    › Primary publication · 12691686 (PubMed)
12. Grief response of the primary caregiver receiving bereavement follow-up care at home. Wujcik D (1984) Am J Hosp Care 1(4): 15-22
    › Primary publication · 10283961 (PubMed)
13. Development of a short version of the Barriers Questionnaire. Wells N, Johnson RL, Wujcik D (1998) J Pain Symptom Manage 15(5): 294-8
    › Primary publication · 9654834 (PubMed)
14. Future considerations in transplantation. Wujcik D (1997) Semin Oncol Nurs 13(3): 216-8
    › Primary publication · 9276915 (PubMed)
15. Update on the diagnosis of and therapy for acute promyelocytic leukemia and chronic myelogenous leukemia. Wujcik D (1996) Oncol Nurs Forum 23(3): 478-87
    › Primary publication · 8801508 (PubMed)
16. An odyssey into biologic therapy. Wujcik D (1993) Oncol Nurs Forum 20(6): 879-87
    › Primary publication · 8367342 (PubMed)
17. Infection control in oncology patients. Wujcik D (1993) Nurs Clin North Am 28(3): 639-50
    › Primary publication · 8367330 (PubMed)
18. Selected complications of allogeneic bone marrow transplantation. Wujcik D, Ballard B, Camp-Sorrell D (1994) Semin Oncol Nurs 10(1): 28-41
    › Primary publication · 8165376 (PubMed)
19. Intravenous immunoglobulin administration: an evaluation of vital sign monitoring. Camp-Sorrell D, Wujcik D (1994) Oncol Nurs Forum 21(3): 531-5
    › Primary publication · 8052549 (PubMed)
20. Meningeal carcinomatosis: diagnosis, treatment, and nursing care. Wujcik D (1983) Oncol Nurs Forum 10(2): 35-40
    › Primary publication · 6553319 (PubMed)
21. Chemotherapy administration. Wujcik D (1987) Cancer Nurs 10(1): 53-64
    › Primary publication · 3644697 (PubMed)
22. Patient controlled analgesia. Wujcik D, Roach AC (1986) Oncol Nurs Forum 13(4): 93
    › Primary publication · 2873558 (PubMed)
23. Options for postremission therapy in acute leukemia. Wujcik D (1990) Semin Oncol Nurs 6(1): 25-30
    › Primary publication · 2406825 (PubMed)
24. Current research in side effects of high-dose chemotherapy. Wujcik D (1992) Semin Oncol Nurs 8(2): 102-12
    › Primary publication · 1621001 (PubMed)
25. Bone marrow transplantation. Wujcik D, Downs S (1992) Crit Care Nurs Clin North Am 4(1): 149-66
    › Primary publication · 1567604 (PubMed)
26. Checking vital signs unnecessary with IVIG administration. Camp-Sorrell D, Wujcik D (1992) Oncol Nurs Forum 19(9): 1433
    › Primary publication · 1437679 (PubMed)
27. Cutaneous toxicity associated with high-dose cytosine arabinoside. Richards C, Wujcik D (1992) Oncol Nurs Forum 19(8): 1191-5
    › Primary publication · 1408960 (PubMed)

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword